当前位置： SCI文献检索 > SKELETAL RADIOLOGY期刊下所有文献 > Desmoid fibromatosis: MRI features of response to systemic therapy.

Desmoid fibromatosis: MRI features of response to systemic therapy.

Abstract：

OBJECTIVE:Imaging criteria for measuring the response of desmoid fibromatosis to systemic therapy are not well established. We evaluated a series of patients with desmoids who underwent systemic therapy to document magnetic resonance imaging (MRI) features associated with a positive clinical response. MATERIALS AND METHODS:This Institutional Review Board-approved retrospective study included 23 patients (mean age 40.5) with 29 extra-abdominal tumors. Therapeutic regimens included cytotoxic chemotherapy (n = 19), targeted therapy (n = 3), and nonsteroid anti-inflammatory drugs (NSAIDS; n = 1). Clinical effects were categorized as progressive disease, stable, or partial response. Maximum tumor dimension (Dmax), approximate tumor volume (VTumor), and quantitative tumor T2 hyperintensity and contrast enhancement (relative to muscle) for pre- and post-treatment MRIs were compared. RESULTS:Three lesions progressed, 5 lesions were stable, whereas 21 showed a clinical response. Dmax decreased more in responders (mean -11.0 %) than in stable/progressive lesions (mean -3.6 and 0 % respectively, p = 0.28, ANOVA); by Response Evaluation Criteria in Solid Tumors (RECIST 1.1) 27 out of 29 lesions were "stable," including the 3 progressive lesions. In responders, VTumor change averaged -29.4 %, but -19.2 % and +32.5 % in stable and progressive lesions respectively (p = 0.002, ANOVA); by 3D criteria 14 out of 29 lesions showed a partial response. T2 hyperintensity decreased by 50-54 % in partial response/stable disease, but only by 10 % in progressive lesions (p = 0.049, t test). Changes in contrast enhancement ranged from -23 % to 0 %, but were not statistically significant among response groups (p = 0.37). Change in T2 hyperintensity showed a positive correlation with volumetric change (r = 0.40). CONCLUSION:Decreases in volume and T2 hyperintensity reflect the positive response of desmoid fibromatosis to systemic therapy; RECIST 1.1 criteria are not sensitive to clinically determined tumor response.

journal_name

Skeletal Radiol

journal_title

Skeletal radiology

authors

Sheth PJ,Del Moral S,Wilky BA,Trent JC,Cohen J,Rosenberg AE,Temple HT,Subhawong TK

doi

10.1007/s00256-016-2439-y

subject

Has Abstract

pub_date

2016-10-01 00:00:00

pages

1365-73

issue

eissn

0364-2348

issn

1432-2161

pii

10.1007/s00256-016-2439-y

journal_volume

pub_type

杂志文章

在线工具

Desmoid fibromatosis: MRI features of response to systemic therapy.